NYSE · LLY
Eli Lilly and Company
$1,425.20+$51.50 (+3.75%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 1.57% below the high.
Loading market information…
CNQ · MSVN.CN · CAD
Stock price, earnings
Quote as of Apr 4, 2022, 02:44 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow ManifestSeven Holdings Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ManifestSeven Holdings Corporation delivers an integrated, multi-channel platform for the legal cannabis market. The company operates through three key divisions: M7 Regulated, Inc., M7 Unregulated, Inc., and M7 Solutions, LLC. Its physical infrastructure includes industrial warehouses and retail storefronts supporting cannabis distribution, delivery, and dispensary services. Additionally, it is involved in the wholesale, distribution, and retail of ancillary products, serving both licensed cannabis operators and other related businesses. ManifestSeven offers financial services, alongside capital hub functionalities and non-financial assistance for brand building and intellectual property. Moreover, it supplies compliant commercial services to licensed cannabis cultivators, manufacturers, distributors, and retailers. ManifestSeven Holdings Corporation's headquarters are located in Irvine, California.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:09 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,425.20+$51.50 (+3.75%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 1.57% below the high.
$276.68+$1.48 (+0.54%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 1.85% below the high.
$295.70+$4.91 (+1.69%)
AbbVie Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.02% below the high.
$409.13-$1.78 (-0.43%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 11.37% below the high.
$0.00$0.00 (0.0%)
Aion Therapeutic Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.89% below the high.
CA$0.36CA$0.00 (0.0%)
Acerus Pharmaceuticals Corporation’s quoted price sits in the lower half of its reported 52-week range, 96.4% below the high.
CA$0.05CA$0.00 (0.0%)
Craftport Cannabis Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
THC Biomed Intl Ltd.’s quoted price sits in the lower half of its reported 52-week range, 95.92% below the high.
